Purchase Order HHSF223201510532P

The Food and Drug Administration (FDA) has awarded a $802,650.92 firm-fixed-price delivery order contract to Labstat International Inc., a foreign-owned, for-profit analytical testing laboratory, to conduct chemical characterization of e-liquids and aerosols from electronic nicotine delivery systems (ENDS) containing non-tobacco nicotine. This work supports the FDA's regulatory oversight of tobacco products. The contract has an ultimate completion date of January 19, 2027 and was not set aside...

This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...

This federal contract award to Labstat International Inc., a leading analytical testing laboratory, is for a stability study of cigarette tobacco filler on behalf of the Food and Drug Administration (FDA). The firm fixed price delivery order is valued at $112,994.60 and has a completion date of June 13, 2016. Labstat has been awarded multiple prior contracts from the FDA to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products in support...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Labstat...

This is a $345,181.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Nielsen Government And Public Sector, LLC, a for-profit limited liability company, for the purchase of tobacco products sales and marketing data. The contract has no set-aside designation and was awarded on September 19, 2012, with a completion date of September 23, 2016. The place of performance is New York, NY 10003, USA. This appears to be a standalone contract...

This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...

This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to The Fox Foundation Inc., a non-profit organization, for $3,408,203.00. The contract is to conduct a randomized, double-blinded, within-subjects, crossover clinical laboratory study to determine whether abuse liability, as measured by nicotine exposure, subjective measures, and product use behavior, differs between e-liquids formulated with tobacco-derived nicotine (TDN) and non-tobacco...

The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...

This is a $1,847,030 delivery order contract awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for comparative pharmacokinetics and in vivo genetic toxicology studies of N-Nitrosonornicotine (NNN) in rats. The work is being performed under the FDA's "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract has a firm fixed price...

This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Lab Depot, Inc., a for-profit, veteran-owned small business subchapter S corporation, to provide tobacco products for the CDC's Tobacco and Volatiles Branch (TVB) laboratory. The contract has a completion date of September 30, 2016 and a ceiling value of $130,981.83. The Lab Depot, Inc. has previously received other federal contract awards from agencies such as the Department of the...